Loading company…
Molecular Axiom researches nucleic acid drugs and drug delivery technologies.
Based in Shanghai, Molecular Axiom researches nucleic acid drugs for cancer, central nervous system, lung and skin diseases. The company also develops nucleic acid drug delivery technologies, including inhalation delivery for cancer and inflammatory diseases. It was established in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in